Literature DB >> 29140572

Dissecting human ILC heterogeneity: more than just three subsets.

Yannick Simoni1, Evan W Newell1.   

Abstract

Innate lymphoid cells (ILCs) have been divided into three distinct groups based on functional capacities, cytokine profiles and transcription factor expression. Studies performed mainly in mice have demonstrated the importance of ILCs in chronic inflammation, infection, allergy and cancer. In this review, we discuss the heterogeneity of human ILC and focus primarily on the taxonomy of human ILC cell subsets and their phenotypical and functional diversity. We summarize recent findings concerning the diversity of ILCs between and within the major subsets [natural killer (NK), ILC1, intra-epithelial ILC1 (ieILC1), ILC2, ILC3, lymphoid tissues inducer (LTi) and ILC progenitor (ILCP)], as well as the abundance of each in human tissues. We also discuss the similarities observed between groups of cells in term of receptors expressed and cytokines produced, and how these relate to the pleiotropic properties of each subset.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  ILC1; ILC2; ILC3; heterogeneity; human; ieILC1

Mesh:

Substances:

Year:  2017        PMID: 29140572      PMCID: PMC5795188          DOI: 10.1111/imm.12862

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  85 in total

Review 1.  Innate lymphoid cells: major players in inflammatory diseases.

Authors:  Mikaël Ebbo; Adeline Crinier; Frédéric Vély; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2017-08-14       Impact factor: 53.106

2.  ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity.

Authors:  Hadi Maazi; Nisheel Patel; Ishwarya Sankaranarayanan; Yuzo Suzuki; Diamanda Rigas; Pejman Soroosh; Gordon J Freeman; Arlene H Sharpe; Omid Akbari
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

3.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

4.  ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.

Authors:  Daniela Paclik; Christina Stehle; Annette Lahmann; Andreas Hutloff; Chiara Romagnani
Journal:  Eur J Immunol       Date:  2015-08-31       Impact factor: 5.532

5.  Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Authors:  Laurent Gauthier; Myriam Baratin; Sophie Guia; Aurore Fenis; Emilie Narni-Mancinelli; Ala-Eddine Deghmane; Benjamin Rossi; Patrick Fourquet; Bertrand Escalière; Yann M Kerdiles; Sophie Ugolini; Muhamed-Kheir Taha; Eric Vivier
Journal:  Sci Immunol       Date:  2017-04-28

6.  Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.

Authors:  David R Withers; Matthew R Hepworth; Xinxin Wang; Emma C Mackley; Emily E Halford; Emma E Dutton; Clare L Marriott; Verena Brucklacher-Waldert; Marc Veldhoen; Judith Kelsen; Robert N Baldassano; Gregory F Sonnenberg
Journal:  Nat Med       Date:  2016-02-15       Impact factor: 53.440

7.  Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.

Authors:  Maryam Salimi; Luzheng Xue; Helen Jolin; Clare Hardman; David J Cousins; Andrew N J McKenzie; Graham S Ogg
Journal:  J Immunol       Date:  2015-11-18       Impact factor: 5.422

8.  A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

Authors:  Maryam Salimi; Jillian L Barlow; Sean P Saunders; Luzheng Xue; Danuta Gutowska-Owsiak; Xinwen Wang; Li-Chieh Huang; David Johnson; Seth T Scanlon; Andrew N J McKenzie; Padraic G Fallon; Graham S Ogg
Journal:  J Exp Med       Date:  2013-12-09       Impact factor: 14.307

9.  CXCR6 marks a novel subset of T-bet(lo)Eomes(hi) natural killer cells residing in human liver.

Authors:  Kerstin A Stegmann; Francis Robertson; Navjyot Hansi; Upkar Gill; Celeste Pallant; Theodoros Christophides; Laura J Pallett; Dimitra Peppa; Claire Dunn; Giuseppe Fusai; Victoria Male; Brian R Davidson; Patrick Kennedy; Mala K Maini
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

10.  Evidence of innate lymphoid cell redundancy in humans.

Authors:  Frédéric Vély; Vincent Barlogis; Blandine Vallentin; Bénédicte Neven; Christelle Piperoglou; Mikael Ebbo; Thibaut Perchet; Maxime Petit; Nadia Yessaad; Fabien Touzot; Julie Bruneau; Nizar Mahlaoui; Nicolas Zucchini; Catherine Farnarier; Gérard Michel; Despina Moshous; Stéphane Blanche; Arnaud Dujardin; Hergen Spits; Jörg H W Distler; Andreas Ramming; Capucine Picard; Rachel Golub; Alain Fischer; Eric Vivier
Journal:  Nat Immunol       Date:  2016-09-12       Impact factor: 25.606

View more
  22 in total

1.  Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function.

Authors:  Shiyang Li; John W Bostick; Jian Ye; Ju Qiu; Bin Zhang; Joseph F Urban; Dorina Avram; Liang Zhou
Journal:  Immunity       Date:  2018-11-13       Impact factor: 31.745

2.  Cytomegalovirus Evades TRAIL-Mediated Innate Lymphoid Cell 1 Defenses.

Authors:  Gaelle Picarda; Raima Ghosh; Bryan McDonald; Shilpi Verma; Nicolas Thiault; Rachid El Morabiti; Thomas S Griffith; Chris A Benedict
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

Review 3.  Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE.

Authors:  Luc Van Kaer; Joshua L Postoak; Chuan Wang; Guan Yang; Lan Wu
Journal:  Cell Mol Immunol       Date:  2019-03-15       Impact factor: 11.530

4.  Role of NK Cells in Tumor Progression.

Authors:  Iñigo Terrén; Francisco Borrego
Journal:  Exp Suppl       Date:  2022

5.  Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment.

Authors:  Giuseppe Sconocchia; Giulia Lanzilli; Valeriana Cesarini; Domenico A Silvestris; Katayoun Rezvani; Roberto Arriga; Sara Caratelli; Ken Chen; Jinzhuang Dou; Carlo Cenciarelli; Gabriele Toietta; Silvia Baldari; Tommaso Sconocchia; Francesca De Paolis; Anna Aureli; Giandomenica Iezzi; Maria Irno Consalvo; Francesco Buccisano; Maria I Del Principe; Luca Maurillo; Adriano Venditti; Alessio Ottaviani; Giulio C Spagnoli
Journal:  Life Sci Alliance       Date:  2022-10-14

Review 6.  Update: Innate Lymphoid Cells in Inflammatory Bowel Disease.

Authors:  Weiwei Luo; Li Tian; Bei Tan; Zhaohua Shen; Mengwei Xiao; Shuai Wu; Xiangrui Meng; Xing Wu; Xiaoyan Wang
Journal:  Dig Dis Sci       Date:  2021-02-20       Impact factor: 3.199

7.  Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps.

Authors:  Aiko I Klingler; Whitney W Stevens; Bruce K Tan; Anju T Peters; Julie A Poposki; Leslie C Grammer; Kevin C Welch; Stephanie S Smith; David B Conley; Robert C Kern; Robert P Schleimer; Atsushi Kato
Journal:  J Allergy Clin Immunol       Date:  2020-12-14       Impact factor: 10.793

8.  Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment.

Authors:  Uriel Y Moreno-Nieves; Joshua K Tay; Saumyaa Saumyaa; Nina B Horowitz; June Ho Shin; Imran A Mohammad; Bogdan Luca; David C Mundy; Gunsagar S Gulati; Nikita Bedi; Serena Chang; Chen Chen; Michael J Kaplan; Eben L Rosenthal; F Christopher Holsinger; Vasu Divi; Fred M Baik; Davud B Sirjani; Andrew J Gentles; Aaron M Newman; Aharon G Freud; John B Sunwoo
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

Review 9.  The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis.

Authors:  Michael P Schön; Luise Erpenbeck
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561

Review 10.  Innate Lymphocytes in Adipose Tissue Homeostasis and Their Alterations in Obesity and Colorectal Cancer.

Authors:  Manuela Del Cornò; Lucia Conti; Sandra Gessani
Journal:  Front Immunol       Date:  2018-11-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.